Trustmark National Bank Trust Department’s Charles River Laboratories CRL Stock Holding History

Trustmark National Bank Trust Department’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-344	Closed	-$49K	–	306
2019 Q2	$49K	Hold	344	–	–	﹤0.01%	352
2019 Q1	$50K	Hold	344	–	–	0.01%	342
2018 Q4	$39K	Hold	344	–	–	﹤0.01%	359
2018 Q3	$46K	Buy	+344	New	+$42.5K	﹤0.01%	363

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trustmark National Bank Trust Department's CRL Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of Charles River Laboratories (CRL) in Q3 2019, closing a stake of 344 shares — an estimated $49K sold.

Trustmark National Bank Trust Department first reported a position in CRL in Q3 2018 and held it in 4 quarters. The position peaked at $50K in Q1 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining Charles River Laboratories position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 344 Charles River Laboratories shares in Q3 2019, an estimated $49K.
Trustmark National Bank Trust Department first reported a position in Charles River Laboratories in Q3 2018 and held it in 4 quarters.
Trustmark National Bank Trust Department's Charles River Laboratories position peaked at $50K in Q1 2019.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.